IOMX THERAPEUTICS AG has a total of 21 patent applications. It increased the IP activity by 200.0%. Its first patent ever was published in 2017. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, GOVERNMENT OF THE U S A AS REP and US HEALTH.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | United States | 3 | |
#4 | Australia | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | Israel | 1 | |
#8 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Medical technology | |
#6 | IT methods for management |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials | |
#4 | Heterocyclic compounds | |
#5 | Microorganisms | |
#6 | Peptides | |
#7 | Diagnosis and surgery | |
#8 | Data processing systems |
# | Name | Total Patents |
---|---|---|
#1 | Khandelwal Nisit | 20 |
#2 | Meier-Ewert Sebastian | 15 |
#3 | Michels Tillmann | 14 |
#4 | Beckhove Philipp | 14 |
#5 | Volpin Valentina | 13 |
#6 | Sennhenn Peter | 13 |
#7 | Breinig Marco | 10 |
#8 | Sorrentino Antonio | 10 |
#9 | Boutros Michael | 10 |
#10 | Menevse Ayse | 6 |
Publication | Filing date | Title |
---|---|---|
WO2021005009A1 | Antibodies binding igc2 of igsf11 (vsig3) and uses thereof | |
WO2019202160A2 | A 5-thiazolecarboxamide kinase inhibitor and uses thereof | |
EP3643713A1 | Heterocyclic kinase inhibitors and uses thereof | |
EP3508499A1 | Antibodies targeting, and other modulators of, an immunoglobulin gene associated with resistance against anti-tumour immune responses, and uses thereof | |
US2020024347A1 | Or10h1 antigen binding proteins and uses thereof | |
EP3391907A1 | Intracellular kinase sik3 associated with resistance against anti-tumour immune responses, and uses thereof |